Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8169417rdf:typepubmed:Citationlld:pubmed
pubmed-article:8169417lifeskim:mentionsumls-concept:C0032305lld:lifeskim
pubmed-article:8169417lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:8169417lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:8169417lifeskim:mentionsumls-concept:C0005149lld:lifeskim
pubmed-article:8169417lifeskim:mentionsumls-concept:C0068527lld:lifeskim
pubmed-article:8169417lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8169417lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:8169417lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:8169417pubmed:issue5lld:pubmed
pubmed-article:8169417pubmed:dateCreated1994-6-2lld:pubmed
pubmed-article:8169417pubmed:abstractTextForty-three human immunodeficiency virus-infected patients with Pneumocystis carinii pneumonia (PCP) were enrolled in a study of adjunctive corticosteroid treatment for 10 days versus placebo, in addition to antimicrobial treatment. Levels of neopterin and beta 2-microglobulin (beta 2M) were determined in consecutive serum samples. Initiation of antimicrobial treatment resulted in significantly increased neopterin levels, whereas beta 2M levels slightly decreased from pretreatment levels. In patients treated with corticosteroid, both neopterin and beta 2M decreased, by approximately 50% and approximately 30%, respectively, and returned to baseline after discontinuation of corticosteroid treatment. Antimicrobial treatment alone did not affect either neopterin or beta 2M in healthy controls. Results indicate that treatment has a differential effect on the immune response: increased macrophage activation leading to neopterin production and decreased production of beta 2M by lymphocytes. Further, addition of corticosteroids modified and decreased this immune activation and may explain the earlier demonstrated beneficial effect of corticosteroids in PCP treatment.lld:pubmed
pubmed-article:8169417pubmed:languageenglld:pubmed
pubmed-article:8169417pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8169417pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8169417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8169417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8169417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8169417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8169417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8169417pubmed:statusMEDLINElld:pubmed
pubmed-article:8169417pubmed:monthMaylld:pubmed
pubmed-article:8169417pubmed:issn0022-1899lld:pubmed
pubmed-article:8169417pubmed:authorpubmed-author:HofmannBBlld:pubmed
pubmed-article:8169417pubmed:authorpubmed-author:JensenB NBNlld:pubmed
pubmed-article:8169417pubmed:authorpubmed-author:LundgrenJ DJDlld:pubmed
pubmed-article:8169417pubmed:authorpubmed-author:NielsenT LTLlld:pubmed
pubmed-article:8169417pubmed:authorpubmed-author:SchattenkerkJ...lld:pubmed
pubmed-article:8169417pubmed:authorpubmed-author:BenfieldT LTLlld:pubmed
pubmed-article:8169417pubmed:issnTypePrintlld:pubmed
pubmed-article:8169417pubmed:volume169lld:pubmed
pubmed-article:8169417pubmed:ownerNLMlld:pubmed
pubmed-article:8169417pubmed:authorsCompleteYlld:pubmed
pubmed-article:8169417pubmed:pagination1170-3lld:pubmed
pubmed-article:8169417pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8169417pubmed:meshHeadingpubmed-meshheading:8169417-...lld:pubmed
pubmed-article:8169417pubmed:meshHeadingpubmed-meshheading:8169417-...lld:pubmed
pubmed-article:8169417pubmed:meshHeadingpubmed-meshheading:8169417-...lld:pubmed
pubmed-article:8169417pubmed:meshHeadingpubmed-meshheading:8169417-...lld:pubmed
pubmed-article:8169417pubmed:meshHeadingpubmed-meshheading:8169417-...lld:pubmed
pubmed-article:8169417pubmed:meshHeadingpubmed-meshheading:8169417-...lld:pubmed
pubmed-article:8169417pubmed:meshHeadingpubmed-meshheading:8169417-...lld:pubmed
pubmed-article:8169417pubmed:meshHeadingpubmed-meshheading:8169417-...lld:pubmed
pubmed-article:8169417pubmed:meshHeadingpubmed-meshheading:8169417-...lld:pubmed
pubmed-article:8169417pubmed:meshHeadingpubmed-meshheading:8169417-...lld:pubmed
pubmed-article:8169417pubmed:meshHeadingpubmed-meshheading:8169417-...lld:pubmed
pubmed-article:8169417pubmed:meshHeadingpubmed-meshheading:8169417-...lld:pubmed
pubmed-article:8169417pubmed:meshHeadingpubmed-meshheading:8169417-...lld:pubmed
pubmed-article:8169417pubmed:year1994lld:pubmed
pubmed-article:8169417pubmed:articleTitleDifferential effect on serum neopterin and serum beta 2-microglobulin is induced by treatment in Pneumocystis carinii pneumonia.lld:pubmed
pubmed-article:8169417pubmed:affiliationDepartment of Infectious Diseases, Hvidovre Hospital, University of Copenhagen, Netherlands.lld:pubmed
pubmed-article:8169417pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8169417pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8169417pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:8169417pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8169417lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8169417lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8169417lld:pubmed